1 year return (CAGR)
108.81%
Oramed Pharmaceuticals Inc Exchange (NASDAQ, USD)
ORMP
4.79
+0.07 (+1.50%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
17.93%
5 year return (CAGR)
-24.65%
10 year return (CAGR)
-4.34%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
197.17M
Price/Sales
-
Ent value
234.10M
Price/Book
0.62
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-195.04%
Trailing P/E
1.13
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.65 |
| Daily high | 4.80 |
| Daily low | 4.61 |
| Daily Volume | 805K |
| All-time high | 29.75 |
| 1y analyst estimate | 7.00 |
| Beta | 1.19 |
| EPS (TTM) | 4.11 |
| Dividend per share | 0.00 |
| Ex-div date | 16 Jan 2026 |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ORMP | S&P500 | |
| Current price drop from All-time high | -83.90% | -1.38% |
| Highest price drop | -94.25% | -56.47% |
| Date of highest drop | 1 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -70.79% | -10.68% |
| Avg time to new high | 223 days | 12 days |
| Max time to new high | 1971 days | 1805 days |
News
